Download presentation
Presentation is loading. Please wait.
Published byชิด สโตเกอร์ Modified over 5 years ago
1
Effect of systemic β-agonist therapy on IgE production in allergic subjects in vivo
Jonathan M. Corne, MRCPa, Catherine H. Linaker, BNa, Peter H. Howarth, DMa, Laurie C.K. Lau, PhDa, Terrence Merrett, PhDb, Richard Beasely, MDc, Martin Church, DSca Journal of Allergy and Clinical Immunology Volume 102, Issue 5, Pages (November 1998) DOI: /S (98) Copyright © 1998 Mosby, Inc. Terms and Conditions
2
Fig. 1 Box and whisker plot showing median, interquartile range, and range for total symptom scores for placebo- (hatched squares) and salbutamol-treated groups. Significant differences between placebo- and salbutamol-treated groups are marked. Journal of Allergy and Clinical Immunology , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions
3
Fig. 2 Box and whisker plot showing median, interquartile range, and range for number of astemizole tablets taken in placebo- (hatched squares) and salbutamol-treated groups. Journal of Allergy and Clinical Immunology , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions
4
Fig. 3 Changes in serum IgE, expressed as serum IgE in August to serum IgE in April, for salbutamol- and placebo-treated groups. Journal of Allergy and Clinical Immunology , DOI: ( /S (98) ) Copyright © 1998 Mosby, Inc. Terms and Conditions
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.